ATH434 dose level 1 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
17	多系統萎縮症	1

17. 多系統萎縮症

臨床試験数 : 119 / 薬物数 : 138 - (DrugBank : 44) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 111

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05109091 (ClinicalTrials.gov)	July 1, 2022	22/10/2021	Study of ATH434 in Participants With Multiple System Atrophy	A Randomized, Double-Blind, Placebo-Controlled Study of ATH434 in Multiple System Atrophy	Multiple System Atrophy	Drug: ATH434 dose level 1;Drug: ATH434 dose level 2;Drug: Placebo	Alterity Therapeutics	NULL	Recruiting	30 Years	75 Years	All	60	Phase 2	United States;Australia;Italy;New Zealand;United Kingdom

First Previous1Next Last